Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $7.4000 (-7.5%) ($7.4000 - $7.4000) on Mon. Apr. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 42.21% (three month average) | RSI | 20 | Latest Price | $7.4000(-7.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -4% a day on average for past five trading days. | Weekly Trend | EYES declines -26% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) VIXM(45%) MCHI(36%) VXX(33%) KWEB(32%) FXI(28%) | Factors Impacting EYES price | EYES will decline at least -21.105% in a week (0% probabilities). TIP(-36%) EWJ(-29%) HYG(-28%) XLI(-27%) XHB(-26%) | | | | | Relative Volatility | | | | Market Trend Strength | -21.105% (StdDev 42.21%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.18 | 5 Day Moving Average | $7.94(-6.8%) | 10 Day Moving Average | $8.9(-16.85%) | 20 Day Moving Average | $11.18(-33.81%) | To recent high | -52.2% | To recent low | 27.8% | Market Cap | $2.364b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |